Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies

被引：0
|
作者：
Arlene D. Stark
Shaun Jordan
Kelly A. Allers
Robert L. Bertekap
Ruoyan Chen
Tanaz Mistry Kannan
Thaddeus F. Molski
Frank D. Yocca
Trevor Sharp
Tetsuro Kikuchi
Kevin D. Burris
机构：
[1] Bristol-Myers Squibb Pharmaceutical Research Institute,Neuroscience Drug Discovery
[2] Otsuka Maryland Research Institute,Department of Pharmacology
[3] Inc.,undefined
[4] Oxford University,undefined
[5] Otsuka Pharmaceutical Co. Ltd.,undefined
[6] Palatin Technologies,undefined
来源：
Psychopharmacology | 2007年 / 190卷
关键词：
Aripiprazole; Dopamine; Serotonin; Schizophrenia; Partial agonist; Antagonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：373 / 382
页数：9
相关论文
共 50 条
  • [31] In vivo characterization of the effects of asenapine at 5-HT1A, 5-HT2A and a2A-adrenergic receptors in the rat brain
    Ghanbari, R.
    El Mansari, M.
    Blier, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S486 - S487
  • [32] Increased binding at 5-HT1A, 5-HT1B, and 5-HT2A receptors and 5-HT transporters in diet-induced obese rats
    Park, S
    Harrold, JA
    Widdowson, PS
    Williams, G
    BRAIN RESEARCH, 1999, 847 (01) : 90 - 97
  • [33] Effects of 5-HT1A Receptor Antagonist and 5-HT2A Receptor Agonist on Morphine Withdrawal
    Ramezani, Mahdi
    Shahidi, Siamak
    Afshar, Simin
    Habibi, Parisa
    Hashemi-Firouzi, Nasrin
    NEUROCHEMICAL JOURNAL, 2024, 18 (02) : 321 - 330
  • [34] Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptors
    Llado-Pelfort, L.
    Assie, M-B
    Newman-Tancredi, A.
    Artigas, F.
    Celada, P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (08) : 1929 - 1940
  • [35] COMPUTATIONAL METHODS IN DETERMINATION OF PHARMACOPHORE MODELS OF 5-HT1A, 5-HT2A AND 5-HT7 RECEPTORS
    Bielenica, Anna
    Kossakowski, Jerzy
    BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO, 2010, (01): : 1 - 12
  • [36] Computational Methods in Determination of Pharmacophore Models of 5-HT1A, 5-HT2A and 5-HT7 Receptors
    Bielenica, Anna
    Koziol, Anna E.
    Struga, Marta
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (07) : 933 - 951
  • [37] Altered 5-HT1A and 5-HT2A receptor interactions in anorexia and bulimia nervosa
    Kaye, Walter H.
    Bailer, U. F.
    Frank, G. K.
    Wagner, A.
    Price, J. C.
    Mathis, C. A.
    Meltzer, C. C.
    NEUROIMAGE, 2008, 41 : T155 - T155
  • [38] Bifeprunox:: a novel atypical antipsychotic with in vivo 5-HT1A receptor agonistic activity
    Herremans, AHJ
    Hertel, P
    Husum, H
    Marquis, K
    Van der Heyden, J
    McCreary, AC
    Hesselink, MB
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S488 - S488
  • [39] Normal 5-HT2A but increased 5-HT1A receptor binding after recovery from bulimia nervosa
    Bailer, Ursula F.
    Frank, Guido K.
    Price, Julie C.
    Meltzer, Carolyn C.
    Mathis, Chester A.
    Wagner, Angela
    Kaye, Walter H.
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 151S - 151S
  • [40] Quantification of 5-HT1A and 5-HT2A receptor Binding in Depressed Suicide Attempters and Non-Attempters
    Mann, J. John
    Metts, Allison V.
    Ogden, R. Todd
    Mathis, Chester A.
    Rubin-Falcone, Harry
    Gong, Zhiqun
    Drevets, Wayne C.
    Zelazny, Jamie
    Brent, David A.
    ARCHIVES OF SUICIDE RESEARCH, 2019, 23 (01) : 122 - 133
12345